The INVOS™ system is the clinical standard in regional oximetry monitoring. It’s also the most widely used regional oximeter in the world([FOOTNOTE=Market share based on data provided by Millennium Research Group.],[ANCHOR=],[LINK=]) – for a reason. The INVOS system has been proven by extensive clinical investigations to improve patient outcomes.([FOOTNOTE=Casati A, Fanelli G, Pietropaoli P, et al. Continuous monitoring of cerebral oxygen saturation in elderly patients undergoing major abdominal surgery minimizes brain exposure to potential hypoxia. Anesth Analg. 2005;101(3):740-747.],[ANCHOR=],[LINK=]),([FOOTNOTE=Murkin JM, Adams SJ, Novick RJ, et al. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg. 2007;104(1):51-58.],[ANCHOR=],[LINK=]) Unique INVOS™ technology enables clinicians to detect subtle, physiologic changes in saturation and cerebral perfusion in order to make timely, critical life-saving decisions for improved patient outcomes.1,2,5
Clinicians around the world have come to rely on the INVOS™ system to guide their decisions in critical situations. Their trust has been earned through both clinical performance and by extensive published research. For those reasons, the INVOS system is the clinical standard in regional oximetry. The only NIRS technology with improved patient outcomes labeling.4,5,([FOOTNOTE=Goldman S, Sutter F, Ferdinand F, Trace C. Optimizing intraoperative cerebral oxygen delivery using noninvasive cerebral oximetry decreases the incidence of stroke for cardiac surgical patients. Heart Surg Forum. 2004;7(5):E376-381.],[ANCHOR=],[LINK=]) The only cerebral oximeter on the market to be tested and validated under varying levels of CO2. Documented clinical performance.3 Clinical studies using the INVOS system demonstrate decreased occurrence of post-operative complications and improved outcomes.4,5